Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior

Brain Structure and Function

Volumn 220, Issue 2, 2015, Pages 605-623

  Hahn, Yun Kyung ^a   Podhaizer, Elizabeth M ^a   Farris, Sean P ^a   Miles, Michael F ^a   Hauser, Kurt F ^a   Knapp, Pamela E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Behavior; HIV 1; NeuroAIDS; Sex; Striatum; Tat

Indexed keywords

TRANSACTIVATOR PROTEIN;

ANIMAL; ANXIETY; ASTROCYTE; CELL COUNT; CORPUS STRIATUM; DENDRITE; FEMALE; GENETICS; MALE; METABOLISM; MICROGLIA; MOUSE; NERVE CELL; OLIGODENDROGLIA; PATHOLOGY; ROTAROD TEST; SEX DIFFERENCE; SYNAPSE; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; ANXIETY; ASTROCYTES; CELL COUNT; CORPUS STRIATUM; DENDRITES; FEMALE; MALE; MICE; MICE, TRANSGENIC; MICROGLIA; NEURONS; OLIGODENDROGLIA; ROTAROD PERFORMANCE TEST; SEX FACTORS; SYNAPSES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84891821284     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-013-0676-6     Document Type: Article

References (124)

1. Adams SM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM (2010) ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling. Synapse 64(11):829–838. doi:10.1002/syn.20793
2. Adams SM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM (2012) Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure. PLoS One 7(5):e37540. doi:10.1371/journal.pone.0037540
3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799. doi:10.1212/01.WNL.0000287431.88658.8b
4. Asin SN, Heimberg AM, Eszterhas SK, Rollenhagen C, Howell AL (2008) Estradiol and progesterone regulate HIV type 1 replication in peripheral blood cells. AIDS Res Hum Retroviruses 24(5):701–716. doi:10.1089/aid.2007.0108
5. Balleine BW, Delgado MR, Hikosaka O (2007) The role of the dorsal striatum in reward and decision-making. J Neurosci 27(31):8161–8165. doi:10.1523/JNEUROSCI.1554-07.2007
6. Basso MR, Bornstein RA (2000) Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. J Clin Exp Neuropsychol 22(2):208–218. doi:10.1076/1380-3395(200004)22:2;1-1;FT208
7. Binh VQ, Chinh NT, Thanh NX, Cuong BT, Quang NN, Dai B, Travers T, Edstein MD (2009) Sex affects the steady-state pharmacokinetics of primaquine but not doxycycline in healthy subjects. Am J Trop Med Hyg 81(5):747–753. doi:10.4269/ajtmh.2009.09-0214
8. Bourin M, Hascoet M (2003) The mouse light/dark box test. Eur J Pharmacol 463(1–3):55–65 pii:S0014299903012743
9. Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998) Variable progression of HIV-associated dementia. Neurology 50(6):1814–1820
10. Brooke S, Chan R, Howard S, Sapolsky R (1997) Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex. Proc Natl Acad Sci USA 94(17):9457–9462
11. Brooks SP, Dunnett SB (2009) Tests to assess motor phenotype in mice: a user’s guide. Nat Rev Neurosci 10(7):519–529. doi:10.1038/nrn2652
12. Bruce-Keller AJ, Dimayuga FO, Reed JL, Wang C, Angers R, Wilson ME, Dimayuga VM, Scheff SW (2007) Gender and estrogen manipulation do not affect traumatic brain injury in mice. J Neurotrauma 24(1):203–215. doi:10.1089/neu.2006.0163
13. Bruce-Keller AJ, Turchan-Cholewo J, Smart EJ, Geurin T, Chauhan A, Reid R, Xu R, Nath A, Knapp PE, Hauser KF (2008) Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 tat transgenic mice. Glia 56(13):1414–1427. doi:10.1002/glia.20708
14. Burger ME, Fachinetto R, Zeni G, Rocha JB (2005) Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain. Pharmacol Biochem Behav 81(3):608–615. doi:10.1016/j.pbb.2005.05.002
15. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28(1):264–278. doi:10.1523/JNEUROSCI.4178-07.2008
16. Carey AN, Sypek EI, Singh HD, Kaufman MJ, McLaughlin JP (2012) Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res 229(1):48–56. doi:10.1016/j.bbr.2011.12.019
17. Carey AN, Liu X, Mintzopoulos D, Paris JJ, Muschamp JW, McLaughlin JP, Kaufman MJ (2013) Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions. Prog Neuropsychopharmacol Biol Psychiatry 43:49–54. doi:10.1016/j.pnpbp.2012.12.018
18. Centers for Disease Control and Prevention (2009) HIV Surveillance Report: Diagnosis of HIV Infection and AIDS in the United States and Dependent Areas, vol 21. http://www.cdc.gov/hiv/topics/surveillance/resources/reports
19. Cheng J, Hurn PD (2010) Sex shapes experimental ischemic brain injury. Steroids 75(11):754–759. doi:10.1016/j.steroids.2009.10.014
20. Cheng HW, Rafols JA, Goshgarian HG, Anavi Y, Tong J, McNeill TH (1997) Differential spine loss and regrowth of striatal neurons following multiple forms of deafferentation: a Golgi study. Exp Neurol 147(2):287–298. doi:10.1006/exnr.1997.6618
21. Chiesi A, Vella S, Dally LG, Pedersen C, Danner S, Johnson AM, Schwander S, Goebel FD, Glauser M, Antunes F et al (1996) Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 11(1):39–44
22. Cho W, Hagemann TL, Johnson DA, Johnson JA, Messing A (2009) Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein. J Neurochem 110(1):343–351. doi:10.1111/j.1471-4159.2009.06146.x
23. Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R, Taylor M, Thompson P, Tate D, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B (2010) Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J Neurovirol 16(6):435–444. doi:10.3109/13550284.2010.520817
24. Corasaniti MT, Amantea D, Russo R, Piccirilli S, Leta A, Corazzari M, Nappi G, Bagetta G (2005) 17β-estradiol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurotoxicology 26(5):893–903. doi:10.1016/j.neuro.2005.01.019
25. Cordeau P Jr, Lalancette-Hebert M, Weng YC, Kriz J (2008) Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury. Stroke 39(3):935–942. doi:10.1161/STROKEAHA.107.501460
26. Coronado VG, Xu L, Basavaraju SV, McGuire LC, Wald MM, Faul MD, Guzman BR, Hemphill JD (2011) Surveillance for traumatic brain injury-related deaths—United States, 1997–2007. MMWR Surveill Summ 60(5):1–32 pii:ss6005a1
27. Crabbe JC, Cotnam CJ, Cameron AJ, Schlumbohm JP, Rhodes JS, Metten P, Wahlsten D (2003) Strain differences in three measures of ethanol intoxication in mice: the screen, dowel and grip strength tests. Genes Brain Behav 2(4):201–213
28. Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13(2):167–170
29. Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4(9):775–790. doi:10.1038/nrd1825
30. D’Astous M, Morissette M, Di Paolo T (2004) Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER α agonist. Neuropharmacology 47(8):1180–1188. doi:10.1016/j.neuropharm.2004.08.020
31. de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535. doi:10.1016/S1474-4422(06)70471-9
32. Dhandapani KM, Wade FM, Mahesh VB, Brann DW (2005) Astrocyte-derived transforming growth factor-{β} mediates the neuroprotective effects of 17{β}-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 146(6):2749–2759. doi:10.1210/en.2005-0014
33. Disshon KA, Dluzen DE (1999) Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: influence of estrogen. Brain Res 842(2):399–407 pii:S0006-8993(99)01863-6
34. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17(10):1539–1545. doi:10.1097/01.aids.0000076282.54156.c3
35. Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8(1):33–44. doi:10.1038/nrn2040
36. European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2011) HIV/AIDS surveillance in Europe 2010. http://www.ecdc.europa.eu/en/publications/publications/111129_sur_annual_hiv_report.ppd
37. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 9(2):209–217
38. Failde-Garrido JM, Alvarez MR, Simon-Lopez MA (2008) Neuropsychological impairment and gender differences in HIV-1 infection. Psychiatry Clin Neurosci 62(5):494–502. doi:10.1111/j.1440-1819.2008.01841.x
39. Farinpour R, Miller EN, Satz P, Selnes OA, Cohen BA, Becker JT, Skolasky RL Jr, Visscher BR (2003) Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol 25(5):654–670. doi:10.1076/jcen.25.5.654.14577
40. Ferrante RJ, Kowall NW, Richardson EP Jr (1991) Proliferative and degenerative changes in striatal spiny neurons in Huntington’s disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci 11(12):3877–3887
41. Fitting S, Booze RM, Hasselrot U, Mactutus CF (2010a) Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study. Hippocampus 20(4):469–480. doi:10.1002/hipo.20648
42. Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, Knapp PE, Hauser KF (2010b) Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol 177(3):1397–1410. doi:10.2353/ajpath.2010.090945
43. Fitting S, Zou S, Chen W, Vo P, Hauser KF, Knapp PE (2010c) Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J Proteome Res 9(4):1795–1804. doi:10.1021/pr900926n
44. Fitting S, Ignatowska-Jankowska BM, Bull C, Skoff RP, Litchman AH, Wise LE, Fox MA, Su J, Medina AE, Krahe TE, Knapp PE, Guido W, Hauser KF (2013) Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type 1 transactivator of transcription transgenic mice. Biol Psychiatry 73(5):443–453. doi:10.1016/j.biopsych.2012.09.026
45. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego
46. Gillies GE, McArthur S (2010) Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson’s disease: a contribution to sex-specific neuroprotection by estrogens. Horm Behav 57(1):23–34. doi:10.1016/j.yhbeh.2009.06.002
47. Giordano G, Tait L, Furlong CE, Cole TB, Kavanagh TJ, Costa LG (2013) Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 expression. Free Radic Biol Med 58:98–108. doi:10.1016/j.freeradbiomed.2013.01.019
48. Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, Robertson K, Yiannoutsos C, Cohen RA, Navia B (2013) Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J Neurovirol. 19(3):209-218. doi:10.1007/s13365-013-0162-1
49. Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5(1):69–81. doi:10.1038/nri1527
50. Goodkin K, Wilkie FL, Concha M, Asthana D, Shapshak P, Douyon R, Fujimura RK, LoPiccolo C (1997) Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Neuroimaging Clin N Am 7(3):561–579
51. Grant I, Heaton RK, Atkinson JH (1995) Neurocognitive disorders in HIV-1 infection. HNRC Group. HIV Neurobehavioral Research Center. Curr Top Microbiol Immunol 202:11–32
52. Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007) Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol 13(3):195–202. doi:10.1080/13550280701258407
53. Gupta S, Knight AG, Knapp PE, Hauser KF, Keller JN, Bruce-Keller AJ (2010) HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter. Neurosci Lett 485(3):233–236. doi:10.1016/j.neulet.2010.09.019
54. Hahn YK, Vo P, Fitting S, Block ML, Hauser KF, Knapp PE (2010) β-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration. J Neurochem 114(1):97–109. doi:10.1111/j.1471-4159.2010.06744.x
55. Hahn YK, Podhaizer EM, Hauser KF, Knapp PE (2012) HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation. Glia 60(12):1871–1887. doi:10.1002/glia.22403
56. Hauser KF, McLaughlin PJ, Zagon IS (1989) Endogenous opioid systems and the regulation of dendritic growth and spine formation. J Comp Neurol 281(1):13–22. doi:10.1002/cne.902810103
57. Hauser KF, Hahn YK, Adjan VV, Zou S, Buch SK, Nath A, Bruce-Keller AJ, Knapp PE (2009) HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology. Glia 57(2):194–206. doi:10.1002/glia.20746
58. Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ et al (1995) The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1(3):231–251
59. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23):2087–2096. doi:10.1212/WNL.0b013e318200d727
60. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3–16. doi:10.1007/s13365-010-0006-1
61. Hel Z, Stringer E, Mestecky J (2010) Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev 31(1):79–97. doi:10.1210/er.2009-0018
62. Helfinstein SM, Fox NA, Pine DS (2012) Approach-withdrawal and the role of the striatum in the temperament of behavioral inhibition. Dev Psychol 48(3):815–826. doi:10.1037/a0026402
63. Herson PS, Koerner IP, Hurn PD (2009) Sex, sex steroids, and brain injury. Semin Reprod Med 27(3):229–239. doi:10.1055/s-0029-1216276
64. Hestad KA, Menon JA, Silalukey-Ngoma M, Franklin DR Jr, Imasiku ML, Kalima K, Heaton RK (2012) Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa. J Nerv Ment Dis 200(4):336–342. doi:10.1097/NMD.0b013e31824cc225
65. Hoffman GE, Merchenthaler I, Zup SL (2006) Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 29(2):217–231. doi:10.1385/ENDO:29:2:217
66. Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R, Nath A (2013) Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci USA 110(33):13588–13593. doi:10.1073/pnas.1308673110
67. Joint United Nations Programme on HIV/AIDS (2010a) Global report: UNAIDS report on the global AIDS epidemic. http://www.unaids.org/globalreport/global_report.htm
68. Joint United Nations Programme on HIV/AIDS (2010b) Outlook: UNAIDS outlook report http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/outlook/2010/20102010_outlook_report_web_en.pdf
69. Jones BJ, Roberts DJ (1968) The quantitative measurement of motor inco-ordination in naive mice using an acelerating rotarod. J Pharm Pharmacol 20(4):302–304
70. Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ (2011) Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav 15(6):1197–1203. doi:10.1007/s10461-010-9744-6
71. Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ (2003) Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol 162(5):1693–1707. doi:10.1016/S0002-9440(10)64304-0
72. Kipp M, Beyer C (2009) Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front Neuroendocrinol 30(2):188–200. doi:10.1016/j.yfrne.2009.04.004
73. Kumar P, Kale RK, McLean P, Baquer NZ (2011) Protective effects of 17β estradiol on altered age related neuronal parameters in female rat brain. Neurosci Lett 502(1):56–60. doi:10.1016/j.neulet.2011.07.024
74. Lawrence DM, Major EO (2002) HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect 4(3):301–308. doi:10.1016/S1286-4579(02)01542-3
75. Lee AW, Mitra D, Laurence J (1997) Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV. AIDS Res Hum Retroviruses 13(14):1235–1242
76. Ligon KL, Fancy SP, Franklin RJ, Rowitch DH (2006) Olig gene function in CNS development and disease. Glia 54(1):1–10. doi:10.1002/glia.20273
77. Liu X, Marder K, Stern Y, Dooneief G, Bell K, Todak G, Joseph M, Elsadr W, Williams JB, Ehrhardt A, Stein Z, Mayeux R (1996) Gender differences in HIV-related neurological progression in a cohort of injecting drug users followed for 3.5 years. J NeuroAIDS 1(4):17–30
78. Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Kim HC, Gash DM, Bing G (2010) Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem 112(3):773–783. doi:10.1111/j.1471-4159.2009.06497.x
79. Lopes M, Olfson M, Rabkin J, Hasin DS, Alegria AA, Lin KH, Grant BF, Blanco C (2012) Gender, HIV status, and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 73(3):384–391. doi:10.4088/JCP.10m06304
80. Lundkvist J, Sundgren-Andersson AK, Tingsborg S, Ostlund P, Engfors C, Alheim K, Bartfai T, Iverfeldt K, Schultzberg M (1999) Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist. Am J Physiol 276(3 Pt 2):R644–R651
81. Maki PM, Martin-Thormeyer E (2009) HIV, cognition and women. Neuropsychol Rev 19(2):204–214. doi:10.1007/s11065-009-9093-2
82. Malmberg-Aiello P, Ipponi A, Bartolini A, Schunack W (2002) Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacol Biochem Behav 71(1–2):313–318. doi:10.1016/S0091-3057(01)00691-8
83. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42(6):963–972. doi:10.1002/ana.410420618
84. McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67(6):699–714. doi:10.1002/ana.22053
85. McNeill TH, Brown SA, Rafols JA, Shoulson I (1988) Atrophy of medium spiny I striatal dendrites in advanced Parkinson’s disease. Brain Res 455(1):148–152. doi:10.1016/0006-8993(88)90124-2
86. Mehal JM, Holman RC, Schonberger LB, Sejvar JJ (2013) Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999–2009. Amyotroph Lateral Scler Frontotemporal Degener. 14(5-6):346-352. doi:10.3109/21678421.2013.787629
87. Mouton PR (2002) Principles and practices of unbiased stereology: an introduction for bioscientists. Johns Hopkins University Press, Baltimore
88. Murray HE, Pillai AV, McArthur SR, Razvi N, Datla KP, Dexter DT, Gillies GE (2003) Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. Neuroscience 116(1):213–222. doi:10.1016/S0306-4522(02)00578-X
89. Nakasujja N, Musisi S, Robertson K, Wong M, Sacktor N, Ronald A (2005) Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. J Neurovirol 11(Suppl 3):26–29. doi:10.1080/13550280500511782
90. Ramezani A, Goudarzi I, Lashkarbolouki T, Ghorbanian MT, Salmani ME, Abrari K (2011) Neuroprotective effects of the 17β-estradiol against ethanol-induced neurotoxicity and oxidative stress in the developing male rat cerebellum: biochemical, histological and behavioral changes. Pharmacol Biochem Behav 100(1):144–151. doi:10.1016/j.pbb.2011.07.010
91. Rao AK, Dietrich AK, Ziegler YS, Nardulli AM (2011) 17β-Estradiol-mediated increase in Cu/Zn superoxide dismutase expression in the brain: a mechanism to protect neurons from ischemia. J Steroid Biochem Mol Biol 127(3–5):382–389. doi:10.1016/j.jsbmb.2011.06.008
92. Rau SW, Dubal DB, Bottner M, Gerhold LM, Wise PM (2003) Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci 23(36):11420–11426
93. Reynolds ES (1963) The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208–212
94. Robertson KR, Kapoor C, Robertson WT, Fiscus S, Ford S, Hall CD (2004) No gender differences in the progression of nervous system disease in HIV infection. J Acquir Immune Defic Syndr 36(3):817–822
95. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21(14):1915–1921. doi:10.1097/QAD.0b013e32828e4e27
96. Roof RL, Hall ED (2000) Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 17(5):367–388
97. Russo R, Navarra M, Maiuolo J, Rotiroti D, Bagetta G, Corasaniti MT (2005) 17β-estradiol protects SH-SY5Y Cells against HIV-1 gp120-induced cell death: evidence for a role of estrogen receptors. Neurotoxicology 26(5):905–913. doi:10.1016/j.neuro.2005.01.009
98. Ryu JK, McLarnon JG (2006) Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid β-peptide-injected rat hippocampus. Exp Neurol 198(2):552–557. doi:10.1016/j.expneurol.2005.12.016
99. Sa MJ, Madeira MD, Ruela C, Volk B, Mota-Miranda A, Paula-Barbosa MM (2004) Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. Acta Neuropathol 107(2):97–110. doi:10.1007/s00401-003-0781-3
100. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001) HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998. Neurology 56(2):257–260
101. Shavali S, Combs CK, Ebadi M (2006) Reactive macrophages increase oxidative stress and α-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson’s disease. Neurochem Res 31(1):85–94. doi:10.1007/s11064-005-9233-x
102. Shin AH, Thayer SA (2013) Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures. Mol Cell Neurosci 54:22–29. doi:10.1016/j.mcn.2012.12.005
103. Shin AH, Kim HJ, Thayer SA (2012) Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat. Br J Pharmacol 166(3):1002–1017. doi:10.1111/j.1476-5381.2011.01805.x
104. Shiotsuki H, Yoshimi K, Shimo Y, Funayama M, Takamatsu Y, Ikeda K, Takahashi R, Kitazawa S, Hattori N (2010) A rotarod test for evaluation of motor skill learning. J Neurosci Methods 189(2):180–185. doi:10.1016/j.jneumeth.2010.03.026
105. Shishehbor MH, Hazen SL (2004) Inflammatory and oxidative markers in atherosclerosis: relationship to outcome. Curr Atheroscler Rep 6(3):243–250
106. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24(9):1243–1250. doi:10.1097/QAD.0b013e3283354a7b
107. Simpkins JW, Yi KD, Yang SH, Dykens JA (2010) Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta 1800(10):1113–1120. doi:10.1016/j.bbagen.2009.11.013
108. Suzuki M, El-Hage N, Zou S, Hahn YK, Sorrell ME, Sturgill JL, Conrad DH, Knapp PE, Hauser KF (2011) Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death. Mol Neurodegener 6:78. doi:10.1186/1750-1326-6-78
109. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348(9025):429–432. doi:10.1016/S0140-6736(96)03356-9
110. Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio ME, Giulianelli M, Noto P, Galgani S, Ippolito G, Antinori A, Narciso P (2005) Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses 21(8):706–713. doi:10.1089/aid.2005.21.706
111. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157(11):1015–1022
112. Viviani B, Gardoni F, Bartesaghi S, Corsini E, Facchi A, Galli CL, Di Luca M, Marinovich M (2006) Interleukin-1 β released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J Biol Chem 281(40):30212–30222. doi:10.1074/jbc.M602156200
113. Voytek B, Knight RT (2010) Prefrontal cortex and basal ganglia contributions to visual working memory. Proc Natl Acad Sci USA 107(42):18167–18172. doi:10.1073/pnas.1007277107
114. Wallace DR, Dodson S, Nath A, Booze RM (2006) Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function. Synapse 59(1):51–60. doi:10.1002/syn.20214
115. Wallace VC, Segerdahl AR, Blackbeard J, Pheby T, Rice AS (2008) Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain. Neurosci Lett 448(1):153–156. doi:10.1016/j.neulet.2008.10.005
116. West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231(4):482–497. doi:10.1002/ar.1092310411
117. Wojna V, Skolasky RL, Hechavarria R, Mayo R, Selnes O, McArthur JC, Melendez LM, Maldonado E, Zorrilla CD, Garcia H, Kraiselburd E, Nath A (2006) Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol 12(5):356–364. doi:10.1080/13550280600964576
118. Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68(5):350–355. doi:10.1212/01.wnl.0000252811.48891.6d
119. Woodruff RH, Tekki-Kessaris N, Stiles CD, Rowitch DH, Richardson WD (2001) Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives. Int J Dev Neurosci 19(4):379–385. doi:10.1016/S0736-5748(00)00083-6
120. Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19(2):152–168. doi:10.1007/s11065-009-9102-5
121. Yang Y, Vidensky S, Jin L, Jie C, Lorenzini I, Frankl M, Rothstein JD (2011) Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice. Glia 59(2):200–207. doi:10.1002/glia.21089
122. Yune TY, Park HG, Lee JY, Oh TH (2008) Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J Neurotrauma 25(9):1121–1131. doi:10.1089/neu.2008.0544
123. Zhang M, Huang Q, Huang Y, Wood O, Yuan W, Chancey C, Daniel S, Rios M, Hewlett I, Clouse KA, Dayton AI (2008) β-Estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL. Retrovirology 5:82. doi:10.1186/1742-4690-5-82
124. Zou W, Kim BO, Zhou BY, Liu Y, Messing A, He JJ (2007) Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. Am J Pathol 171(6):1923–1935. doi:10.2353/ajpath.2007.070333